Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Hyperoxaluria”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04542590
What this trial is testing

Natural History of Patients With PH3 and a History of Stone Events

Who this might be right for
Primary Hyperoxaluria Type 3
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company 7
Testing effectiveness (Phase 2)Study completedNCT02038543
What this trial is testing

Hydroxyproline Influence on Oxalate Metabolism

Who this might be right for
Hyperoxaluria
Mayo Clinic 22
Large-scale testing (Phase 3)Study completedNCT03116685
What this trial is testing

Evaluate the Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria

Who this might be right for
Primary Hyperoxaluria
OxThera 25
Not applicableStudy completedNCT00589225
What this trial is testing

Primary Hyperoxaluria Mutation Genotyping

Who this might be right for
Primary Hyperoxaluria
Mayo Clinic 902
Early research (Phase 1)Study completedNCT03392896
What this trial is testing

Study of DCR-PHXC-101 in Normal Healthy Volunteers and Patients With Primary Hyperoxaluria

Who this might be right for
Primary Hyperoxaluria
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company 43
Testing effectiveness (Phase 2)Study completedNCT01281878
What this trial is testing

Trial on Treatment of Patients With Primary Hyperoxaluria Type I With Pyridoxal-phosphate

Who this might be right for
Primary Hyperoxaluria Type I
University of Cologne 12
Testing effectiveness (Phase 2)Looking for participantsNCT07587021
What this trial is testing

Study of YOLT-203 in Children and Adults With Primary Hyperoxaluria Type 1 (PH1)

Who this might be right for
Primary Hyperoxaluria Type 1PH1
YolTech Therapeutics Co., Ltd 36
Not applicableUnknownNCT05107830
What this trial is testing

Phenotyping of Primary Hyperoxaluria

Who this might be right for
Primary Hyperoxaluria
University Hospital, Strasbourg, France 186
Testing effectiveness (Phase 2)Study completedNCT00283387
What this trial is testing

Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria

Who this might be right for
Hyperoxaluria
Mayo Clinic 15
Not applicableNo Longer AvailableNCT05993416
What this trial is testing

Treatment of Primary Hyperoxaluria Type 1 With Nedosiran

Who this might be right for
Primary Hyperoxaluria Type 1 (PH1)
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
Not applicableStudy completedNCT02830009
What this trial is testing

IDENTIFICATION OF A MULTI-ANALYTE PROFILE FOR PRIMARY HYPEROXALURIA AND COMPARISON WITH HEALTHY SIBLINGS AND IDIOPATHIC HYPERCALCIURIA

Who this might be right for
Primary Hyperoxaluria Type 1Idiopathic Hypercalciuria
Hospices Civils de Lyon 5
Large-scale testing (Phase 3)WithdrawnNCT00280215
What this trial is testing

Renal Protective Effect of ACEI and ARB in Primary Hyperoxaluria

Who this might be right for
Hyperoxaluria
Mayo Clinic
Large-scale testing (Phase 3)Not Yet RecruitingNCT06465472
What this trial is testing

Evaluation of the Efficacy and Safety of Stiripentol in Patients 6 Years and Older With Primary Hyperoxaluria Type 1, 2 or 3

Who this might be right for
Primary Hyperoxaluria Type 1Primary Hyperoxaluria Type 2Primary Hyperoxaluria Type 3
Biocodex 42
Not applicableApproved For MarketingNCT04125472
What this trial is testing

Expanded Access Protocol to Provide Lumasiran to Patients With Primary Hyperoxaluria Type 1

Who this might be right for
Primary Hyperoxaluria
Alnylam Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT04152200
What this trial is testing

Evaluate Lumasiran in Patients With Advanced Primary Hyperoxaluria Type 1

Who this might be right for
Primary Hyperoxaluria Type 1Primary Hyperoxaluria
Alnylam Pharmaceuticals 21
Testing effectiveness (Phase 2)Study completedNCT05001269
What this trial is testing

Nedosiran in Pediatric Patients From Birth to 11 Years of Age With PH and Relatively Intact Renal Function

Who this might be right for
Primary HyperoxaluriaPrimary Hyperoxaluria Type 1Primary Hyperoxaluria Type 2+1 more
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company 27
Not applicableActive Not RecruitingNCT03655223
What this trial is testing

Early Check: Expanded Screening in Newborns

Who this might be right for
Spinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more
RTI International 30,000
Not applicableStudy completedNCT03900260
What this trial is testing

Clinical Evaluation of the Lenstec Softec HP1 Intraocular Lens

Who this might be right for
Aphakia
Lenstec Incorporated 87
Very early researchLooking for participantsNCT06511349
What this trial is testing

Clinical Exploration Study of YOLT-203 in the Treatment of Type 1 Primary Hyperoxaluria (PH1)

Who this might be right for
Type 1 Primary Hyperoxaluria
RenJi Hospital 21
Testing effectiveness (Phase 2)Study completedNCT02012985
What this trial is testing

Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Patients With Primary Hyperoxaluria

Who this might be right for
Primary Hyperoxaluria
OxThera 28
Next Page